An early Alzheimer's treatment that removes amyloid plaques from the brain many years before symptoms arise may help delay ...

Washington University-led research shows a small group of participants in an Alzheimer’s study experienced a significant ...

"They didn't value me as much," the actress says of initially not having the same name recognition as her male co-star The ...

A long-term human trial has found that a discontinued drug halved the presentation of early-onset Alzheimer's disease in ...

A method for slowing disease progress in Alzheimer's patients may also delay onset in people predisposed to the disease who ...

The findings provide new evidence to support the so-called amyloid hypothesis of Alzheimer's disease, which posits that the ...

Since becoming only the second Alzheimer's-modifying drug to gain American Federal Drug Administration approval in 2023, ...

For the first time, scientists say, they have evidence that using a biologic drug to remove sticky beta amyloid plaques from ...

An experimental drug appears to reduce the risk of Alzheimer's-related dementia in people destined to develop the disease in their 30s, 40s or 50s, according to the results of a new study. The ...

Investigators said that the OLE study showed Roche’s gantenerumab dropped the risk of developing Alzheimer's symptoms by 50%.

Leqembi is an infusion therapy that targets and removes the beta-amyloid plaque that builds up in the brains of Alzheimer's patients.

The results boost hopes similar treatments being developed to target more common forms of Alzheimer’s – that appear when ...